Vantrimpont P J, Felice H, Paulus W J
Cardiovascular Center, O.L.V. Ziekenhuis, Aalst, Belgium.
Eur Heart J. 1995 Sep;16(9):1300-6. doi: 10.1093/oxfordjournals.eurheartj.a061089.
The purpose of the study was to evaluate whether infusion of a beta-adrenergic agonist, prior to and during exercise, could compensate for reduced sympathetic stimulation and correct deficient acceleration of left ventricular relaxation, so preventing a rise in left ventricular filling pressures during exercise after cardiac transplantation. Abnormal left ventricular relaxation kinetics can contribute to exercise-induced diastolic dysfunction of the cardiac allograft. This was demonstrated in transplant recipients whose acceleration of left ventricular relaxation during exercise was almost negligible recently and whose elevation of left ventricular end-diastolic pressure was high. Decreased adrenergic tone due to denervation could be involved in deficient left ventricular lusitropic response to exercise, because acceleration of left ventricular relaxation during exercise depends on adequate sympathetic stimulation. Serial supine bicycle exercise was performed at an identical workload in eight transplant recipients while in the control state and during continuous infusion of dobutamine, titrated before exercise to achieve a heart rate matching the heart rate at peak exercise in the control state. During control exercise, heart rate rose from 87 +/- 8 to 104 +/- 12 beats.min-1 (P < 0.05), left ventricular end-diastolic pressure from 14 +/- 5 to 20 +/- 4 mmHg (P < 0.05), left ventricular dP/dtmax from 1374 +/- 172 to 1854 +/- 278 mmHg.s-1 (P < 0.05), and cardiac output from 5.8 +/- 0.9 to 8.5 +/- 1.1 l.min-1 P < 0.05). There was a small but significant decrease of the time constant of left ventricular pressure decay (T) from 42 +/- 6 to 38 +/- 6 ms (P < 0.05). During dobutamine infusion, exercise resulted in a further increase in heart rate from 108 +/- 11 to 122 +/- 17 mmHg (P < 0.05), in cardiac output from 7.4 +/- 0.9 to 10.3 +/- 2.5 l.min-1 (P < 0.05), and in left ventricular dP/dtmax from 2181 +/- 220 to 2620 +/- 214 mmHg.s-1 (P < 0.05). These values were higher than the measurements obtained at the end of the control exercise run (P < 0.05). T failed to change (29 +/- 4 vs 27 +/- 5 mmHg, P > 0.05) and left ventricular end-diastolic pressure increased from 5 +/- 3 to 11 +/- 5 mmHg (P < 0.05) but remained lower than at the end of the control exercise run (11 +/- 5 vs 20 +/- 4 mmHg, P < 0.05). Compensation for reduced sympathetic stimulation by administration of dobutamine improves exercise haemodynamics in cardiac transplant recipients, but cannot prevent the exercise-induced rise in left ventricular end-diastolic pressure and correct deficient acceleration of left ventricular relaxation. Abnormal exercise haemodynamics after heart transplantation are therefore only partly related to deficient sympathetic stimulation.
本研究的目的是评估在运动前及运动过程中输注β-肾上腺素能激动剂是否能够代偿交感神经刺激的降低,并纠正左心室舒张加速不足的情况,从而防止心脏移植术后运动期间左心室充盈压升高。左心室舒张动力学异常可导致心脏移植受者运动诱发的舒张功能障碍。最近在一些移植受者中得到了证实,这些受者运动期间左心室舒张加速几乎可以忽略不计,且左心室舒张末期压力升高明显。由于去神经支配导致的肾上腺素能张力降低可能与运动时左心室舒张功能反应不足有关,因为运动期间左心室舒张加速依赖于充足的交感神经刺激。在8名移植受者处于对照状态及持续输注多巴酚丁胺期间,以相同的工作量进行系列仰卧位自行车运动,运动前多巴酚丁胺剂量滴定至心率与对照状态下运动峰值时的心率相匹配。在对照运动期间,心率从87±8次/分钟升至104±12次/分钟(P<0.05),左心室舒张末期压力从14±5 mmHg升至20±4 mmHg(P<0.05),左心室dP/dtmax从1374±172 mmHg·s-1升至1854±278 mmHg·s-1(P<0.05),心输出量从5.8±0.9升/分钟升至8.5±1.1升/分钟(P<0.05)。左心室压力衰减时间常数(T)从42±6毫秒小幅但显著降至38±6毫秒(P<0.05)。在输注多巴酚丁胺期间,运动导致心率进一步从108±11次/分钟升至122±17次/分钟(P<0.05),心输出量从7.4±0.9升/分钟升至10.3±2.5升/分钟(P<0.05),左心室dP/dtmax从2181±220 mmHg·s-1升至2620±214 mmHg·s-1(P<0.05)。这些值高于对照运动结束时测得的值(P<0.05)。T未改变(29±4毫秒对27±5毫秒,P>0.05),左心室舒张末期压力从5±3 mmHg升至11±5 mmHg(P<0.05),但仍低于对照运动结束时的值(11±5 mmHg对20±4 mmHg,P<0.05)。通过给予多巴酚丁胺代偿交感神经刺激降低可改善心脏移植受者的运动血流动力学,但不能防止运动诱发的左心室舒张末期压力升高,也不能纠正左心室舒张加速不足。因此,心脏移植术后异常的运动血流动力学仅部分与交感神经刺激不足有关。